Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

16.70 +0.20 (+1.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Neogen, Dentsply Sirona, Acadia Healthcare, Universal Health Services, and Mettler-Toledo Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Breaking Down Dentsply Sirona: 9 Analysts Share Their Views
Via Benzinga
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Expert Outlook: Dentsply Sirona Through The Eyes Of 9 Analysts
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Dentsply Sirona Stock Is Rallying The Most Since 2019 on Thursday – What's Driving It?
Dentsply Sirona topped Q1 estimates, raised 2025 sales outlook, and reaffirmed EPS guidance, pushing shares higher despite macroeconomic pressures. 
Via Benzinga
Dentsply Sirona (NASDAQ:XRAY) Beats Expectations in Strong Q1, Stock Soars
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2025, but sales fell by 7.8% year on year to $879 million. The company’s full-year revenue guidance... 
Via StockStory
What To Expect From Dentsply Sirona’s (XRAY) Q1 Earnings
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Unprofitable Stock Worth Investigating and 2 to Approach with Caution
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
Topics Energy
Exposures Electricity Generation
Deep Dive Into Dentsply Sirona Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
1 Value Stock on Our Buy List and 2 to Ignore
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Q4 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
3 Cash-Producing Stocks Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Q4 Earnings Highs And Lows: Envista (NYSE:NVST) Vs The Rest Of The Dental Equipment & Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst... 
Via StockStory
3 Reasons to Avoid XRAY and 1 Stock to Buy Instead
Dentsply Sirona’s stock price has taken a beating over the past six months, shedding 46.9% of its value and falling to $12.92 per share. This was partly due to its softer quarterly results and may have... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
Via Benzinga
3 Stocks Under $50 Skating on Thin Ice
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst
Needham downgraded Dentsply Sirona and ZimVie, citing weak growth, market share losses, and demand challenges amid high interest rates and soft consumer sentiment. 
Via Benzinga
This UiPath Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
3 Value Stocks Skating on Thin Ice
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Dental Equipment & Technology Stocks Q4 Earnings Review: Align Technology (NASDAQ:ALGN) Shines
Let’s dig into the relative performance of Align Technology (NASDAQ:ALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and... 
Via StockStory
Dentsply Sirona Q4: Earnings Miss, 10% Sales Drop, Soft 2025 Outlook And More
Dentsply Sirona Q4 earnings miss estimates with a 10% sales drop, and the company forecasts lower 2025 sales. 
Via Benzinga
Topics Earnings
Exposures Financial
Dentsply Sirona (NASDAQ:XRAY) Misses Q4 Sales Targets, Stock Drops
Dental products company Dentsply Sirona (NASDAQ:XRAY) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 10.6% year on year to $905 million. The company’s full-year revenue... 
Via StockStory
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q4 Results Tomorrow
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be announcing earnings results tomorrow morning. Here’s what you need to know. 
Via StockStory
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating DENTSPLY SIRONA Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.